Cardinal Health Inc (CAH) : Zwj Investment Counsel Inc scooped up 10,969 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 269,978 shares of Cardinal Health Inc which is valued at $22,572,861.Cardinal Health Inc makes up approximately 2.26% of Zwj Investment Counsel Inc’s portfolio.
Other Hedge Funds, Including , Exane Derivatives reduced its stake in CAH by selling 323 shares or 8.6% in the most recent quarter. The Hedge Fund company now holds 3,432 shares of CAH which is valued at $290,484. Cardinal Health Inc makes up approx 0.05% of Exane Derivatives’s portfolio.Evercore Wealth Management reduced its stake in CAH by selling 1,600 shares or 58.82% in the most recent quarter. The Hedge Fund company now holds 1,120 shares of CAH which is valued at $94,797.
Cardinal Health Inc closed down -0.41 points or -0.49% at $83.19 with 13,92,896 shares getting traded on Monday. Post opening the session at $83.25, the shares hit an intraday low of $83.05 and an intraday high of $83.4929 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.